Lexaria Bioscience (LEXX) Stock Statistics & Valuation Metrics

Lexaria Bioscience has a market cap or net worth of $24.67M. The enterprise value is ―.

Lexaria Bioscience has 22,225,845 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lexaria Bioscience’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Lexaria Bioscience is ―. Lexaria Bioscience’s PEG ratio is 0.00.

In the last 12 months, Lexaria Bioscience had revenue of 705.92K and earned -11.90M in profits. Earnings per share was -0.66.

In the last 12 months, operating cash flow was -9.70M and capital expenditures -94.23K, giving a free cash flow of -9.77M billion.

Lexaria Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Lexaria Bioscience upcoming earnings date is ―, ―.

Lexaria Bioscience as a current ratio of ―, with Debt / Equity ratio of 2.10%

In the past 12 months, Lexaria Bioscience has paid 0.00 in taxes.

Lexaria Bioscience EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Lexaria Bioscience has $4.63M in cash and marketable securities with $116.59K in debt, giving a net cash position of $4.51M billion.

Gross margin is 99.56%, with operating margin of ―, and net profit margin of ―.

The average price target for Lexaria Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy